APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Design

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI Drug Design Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 March 2026193 pages

Choose your research edition.

Industry ResearchAI Drug Design Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Design Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI Drug Design Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Design Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Design Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global AI Drug Design market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI Drug Design include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise and Envisagenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI Drug Design market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Design and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Design revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Drug Design market size, projected growth trends, production technologies, key applications, and end-use industries.

AI Drug Design Segment by Company

Exscientia

PathAI

Tempus

Aria Pharmaceuticals

BenchSci

Antidote

AiCure

Atomwise

Envisagenics

Sherlock

Deep Genomics

Benevolent

Iktos

AlmirallShare

AI Drug Design Segment by Type

Therapy Research

Design and Development

Others

AI Drug Design Segment by Application

Cancer

Cardiovascular Disease

Others

AI Drug Design Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Design market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Design and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Design.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Drug Design in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Design industry.

Chapter 3: Detailed analysis of AI Drug Design companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Designrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Design Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Therapy Research Table 3. Key Players of Design and Development Table 4. Key Players of Others Table 4. Global AI Drug Design Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Cardiovascular Disease Table 7. Key Players of Others Table 8. Global AI Drug Design Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global AI Drug Design Market Size by Region (2021-2026) & (US$ Million) Table 10. Global AI Drug Design Market Share by Region (2021-2026) Table 11. Global AI Drug Design Market Size by Region (2027-2032) & (US$ Million) Table 12. Global AI Drug Design Market Share by Region (2027-2032) Table 13. AI Drug Design Industry Trends Table 14. AI Drug Design Industry Drivers Table 15. AI Drug Design Industry Opportunities and Challenges Table 16. AI Drug Design Industry Restraints Table 17. Global AI Drug Design Revenue by Company (US$ Million) & (2021-2026) Table 18. Global AI Drug Design Revenue Market Share by Company (2021-2026) Table 19. Global AI Drug Design Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI Drug Design Key Company Head Office and Area Served Table 21. Global AI Drug Design Company, Product Type & Application Table 22. Global AI Drug Design Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global AI Drug Design by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global AI Drug Design Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 27. Global AI Drug Design Market Size by Type (2027-2032) & (US$ Million) Table 28. Global AI Drug Design Revenue Market Share by Type (2021-2026) Table 29. Global AI Drug Design Revenue Market Share by Type (2027-2032) Table 30. Global AI Drug Design Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 32. Global AI Drug Design Market Size by Application (2027-2032) & (US$ Million) Table 33. Global AI Drug Design Revenue Market Share by Application (2021-2026) Table 34. Global AI Drug Design Revenue Market Share by Application (2027-2032) Table 35. Exscientia Company Information Table 36. Exscientia Business Overview Table 37. Exscientia AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Exscientia AI Drug Design Product Portfolio Table 39. Exscientia Recent Development Table 40. PathAI Company Information Table 41. PathAI Business Overview Table 42. PathAI AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. PathAI AI Drug Design Product Portfolio Table 44. PathAI Recent Development Table 45. Tempus Company Information Table 46. Tempus Business Overview Table 47. Tempus AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Tempus AI Drug Design Product Portfolio Table 49. Tempus Recent Development Table 50. Aria Pharmaceuticals Company Information Table 51. Aria Pharmaceuticals Business Overview Table 52. Aria Pharmaceuticals AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Aria Pharmaceuticals AI Drug Design Product Portfolio Table 54. Aria Pharmaceuticals Recent Development Table 55. BenchSci Company Information Table 56. BenchSci Business Overview Table 57. BenchSci AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. BenchSci AI Drug Design Product Portfolio Table 59. BenchSci Recent Development Table 60. Antidote Company Information Table 61. Antidote Business Overview Table 62. Antidote AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Antidote AI Drug Design Product Portfolio Table 64. Antidote Recent Development Table 65. AiCure Company Information Table 66. AiCure Business Overview Table 67. AiCure AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AiCure AI Drug Design Product Portfolio Table 69. AiCure Recent Development Table 70. Atomwise Company Information Table 71. Atomwise Business Overview Table 72. Atomwise AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Atomwise AI Drug Design Product Portfolio Table 74. Atomwise Recent Development Table 75. Envisagenics Company Information Table 76. Envisagenics Business Overview Table 77. Envisagenics AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Envisagenics AI Drug Design Product Portfolio Table 79. Envisagenics Recent Development Table 80. Sherlock Company Information Table 81. Sherlock Business Overview Table 82. Sherlock AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sherlock AI Drug Design Product Portfolio Table 84. Sherlock Recent Development Table 85. Deep Genomics Company Information Table 86. Deep Genomics Business Overview Table 87. Deep Genomics AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Deep Genomics AI Drug Design Product Portfolio Table 89. Deep Genomics Recent Development Table 90. Benevolent Company Information Table 91. Benevolent Business Overview Table 92. Benevolent AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Benevolent AI Drug Design Product Portfolio Table 94. Benevolent Recent Development Table 95. Iktos Company Information Table 96. Iktos Business Overview Table 97. Iktos AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Iktos AI Drug Design Product Portfolio Table 99. Iktos Recent Development Table 100. AlmirallShare Company Information Table 101. AlmirallShare Business Overview Table 102. AlmirallShare AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. AlmirallShare AI Drug Design Product Portfolio Table 104. AlmirallShare Recent Development Table 105. North America AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 106. North America AI Drug Design Market Size by Type (2027-2032) & (US$ Million) Table 107. North America AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 108. North America AI Drug Design Market Size by Application (2027-2032) & (US$ Million) Table 109. North America AI Drug Design Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America AI Drug Design Market Size by Country (2021-2026) Table 111. North America AI Drug Design Market Size by Country (2027-2032) Table 112. Europe AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe AI Drug Design Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe AI Drug Design Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe AI Drug Design Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe AI Drug Design Market Size by Country (2021-2026) Table 118. Europe AI Drug Design Market Size by Country (2027-2032) Table 119. China AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 120. China AI Drug Design Market Size by Type (2027-2032) & (US$ Million) Table 121. China AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 122. China AI Drug Design Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia AI Drug Design Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia AI Drug Design Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia AI Drug Design Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia AI Drug Design Market Size by Country (2021-2026) Table 129. Asia AI Drug Design Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa AI Drug Design Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa AI Drug Design Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa AI Drug Design Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa AI Drug Design Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa AI Drug Design Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. AI Drug Design Product Image Figure 2. Global AI Drug Design Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI Drug Design Market Share by Type: 2025 VS 2032 Figure 4. Therapy Research Image Figure 5. Design and Development Image Figure 6. Others Image Figure 7. Global AI Drug Design Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global AI Drug Design Market Share by Application: 2025 VS 2032 Figure 9. Cancer Image Figure 10. Cardiovascular Disease Image Figure 11. Others Image Figure 12. Global AI Drug Design Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 14. Global AI Drug Design Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global AI Drug Design Market Share by Players in 2025 Figure 17. Global Top 5 and 10 AI Drug Design Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global AI Drug Design Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Drug Design Revenue Market Share by Type (2021-2032) Figure 21. Global AI Drug Design Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Drug Design Revenue Market Share by Application (2021-2032) Figure 23. North America AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 24. North America AI Drug Design Market Share by Type (2021-2032) Figure 25. North America AI Drug Design Market Share by Application (2021-2032) Figure 26. North America AI Drug Design Market Share by Country (2021-2032) Figure 27. United States AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 28. Canada AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 29. Mexico AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 30. Europe AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 31. Europe AI Drug Design Market Share by Type (2021-2032) Figure 32. Europe AI Drug Design Market Share by Application (2021-2032) Figure 33. Europe AI Drug Design Market Share by Country (2021-2032) Figure 34. Germany AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 35. France AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 36. U.K. AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 37. Italy AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 38. Russia AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 40. China AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 41. China AI Drug Design Market Share by Type (2021-2032) Figure 42. China AI Drug Design Market Share by Application (2021-2032) Figure 43. Asia AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 44. Asia AI Drug Design Market Share by Type (2021-2032) Figure 45. Asia AI Drug Design Market Share by Application (2021-2032) Figure 46. Asia AI Drug Design Market Share by Country (2021-2032) Figure 47. Japan AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 48. South Korea AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 51. India AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 52. Australia AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa AI Drug Design Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa AI Drug Design Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa AI Drug Design Market Share by Country (2021-2032) Figure 57. Brazil AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 58. South Africa AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 60. Turkey AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 61. Argentina AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 62. UAE AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 63. Egypt AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 64. Chile AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Therapy Research
  • Design and Development
  • Others
Applications
  • Cancer
  • Cardiovascular Disease
  • Others
Companies covered
  • Exscientia
  • PathAI
  • Tempus
  • Aria Pharmaceuticals
  • BenchSci
  • Antidote
  • AiCure
  • Atomwise
  • Envisagenics
  • Sherlock
  • Deep Genomics
  • Benevolent
  • Iktos
  • AlmirallShare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI Drug Design Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Therapy Research
  5. 1.2.3 Design and Development
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global AI Drug Design Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Cardiovascular Disease
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global AI Drug Design Growth Trends by Region
  14. 1.5.1 Global AI Drug Design Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 AI Drug Design Market Size by Region (2021-2026)
  16. 1.5.3 AI Drug Design Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global AI Drug Design Market Dynamics
  1. 2.1 AI Drug Design Industry Trends
  2. 2.2 AI Drug Design Industry Drivers
  3. 2.3 AI Drug Design Industry Opportunities and Challenges
  4. 2.4 AI Drug Design Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI Drug Design Revenue by Company (2021-2026)
  2. 3.2 Global AI Drug Design Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI Drug Design Key Company Head office and Area Served
  4. 3.4 Global AI Drug Design Company, Product Type & Application
  5. 3.5 Global AI Drug Design Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI Drug Design Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI Drug Design Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI Drug Design Tier 1, Tier 2, and Tier 3
4 AI Drug Design Market by Type
  1. 4.1 Global AI Drug Design Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI Drug Design Market Size by Type (2021-2032)
  3. 4.3 Global AI Drug Design Market Size Share by Type (2021-2032)
5 AI Drug Design Market by Application
  1. 5.1 Global AI Drug Design Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Design Market Size by Application (2021-2032)
  3. 5.3 Global AI Drug Design Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Exscientia
  2. 6.1.1 Exscientia Company Information
  3. 6.1.2 Exscientia Business Overview
  4. 6.1.3 Exscientia AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Exscientia AI Drug Design Product Portfolio
  6. 6.1.5 Exscientia Recent Developments
  7. 6.2 PathAI
  8. 6.2.1 PathAI Company Information
  9. 6.2.2 PathAI Business Overview
  10. 6.2.3 PathAI AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 PathAI AI Drug Design Product Portfolio
  12. 6.2.5 PathAI Recent Developments
  13. 6.3 Tempus
  14. 6.3.1 Tempus Company Information
  15. 6.3.2 Tempus Business Overview
  16. 6.3.3 Tempus AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Tempus AI Drug Design Product Portfolio
  18. 6.3.5 Tempus Recent Developments
  19. 6.4 Aria Pharmaceuticals
  20. 6.4.1 Aria Pharmaceuticals Company Information
  21. 6.4.2 Aria Pharmaceuticals Business Overview
  22. 6.4.3 Aria Pharmaceuticals AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Aria Pharmaceuticals AI Drug Design Product Portfolio
  24. 6.4.5 Aria Pharmaceuticals Recent Developments
  25. 6.5 BenchSci
  26. 6.5.1 BenchSci Company Information
  27. 6.5.2 BenchSci Business Overview
  28. 6.5.3 BenchSci AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 BenchSci AI Drug Design Product Portfolio
  30. 6.5.5 BenchSci Recent Developments
  31. 6.6 Antidote
  32. 6.6.1 Antidote Company Information
  33. 6.6.2 Antidote Business Overview
  34. 6.6.3 Antidote AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Antidote AI Drug Design Product Portfolio
  36. 6.6.5 Antidote Recent Developments
  37. 6.7 AiCure
  38. 6.7.1 AiCure Company Information
  39. 6.7.2 AiCure Business Overview
  40. 6.7.3 AiCure AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AiCure AI Drug Design Product Portfolio
  42. 6.7.5 AiCure Recent Developments
  43. 6.8 Atomwise
  44. 6.8.1 Atomwise Company Information
  45. 6.8.2 Atomwise Business Overview
  46. 6.8.3 Atomwise AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Atomwise AI Drug Design Product Portfolio
  48. 6.8.5 Atomwise Recent Developments
  49. 6.9 Envisagenics
  50. 6.9.1 Envisagenics Company Information
  51. 6.9.2 Envisagenics Business Overview
  52. 6.9.3 Envisagenics AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Envisagenics AI Drug Design Product Portfolio
  54. 6.9.5 Envisagenics Recent Developments
  55. 6.10 Sherlock
  56. 6.10.1 Sherlock Company Information
  57. 6.10.2 Sherlock Business Overview
  58. 6.10.3 Sherlock AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sherlock AI Drug Design Product Portfolio
  60. 6.10.5 Sherlock Recent Developments
  61. 6.11 Deep Genomics
  62. 6.11.1 Deep Genomics Company Information
  63. 6.11.2 Deep Genomics Business Overview
  64. 6.11.3 Deep Genomics AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Deep Genomics AI Drug Design Product Portfolio
  66. 6.11.5 Deep Genomics Recent Developments
  67. 6.12 Benevolent
  68. 6.12.1 Benevolent Company Information
  69. 6.12.2 Benevolent Business Overview
  70. 6.12.3 Benevolent AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Benevolent AI Drug Design Product Portfolio
  72. 6.12.5 Benevolent Recent Developments
  73. 6.13 Iktos
  74. 6.13.1 Iktos Company Information
  75. 6.13.2 Iktos Business Overview
  76. 6.13.3 Iktos AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Iktos AI Drug Design Product Portfolio
  78. 6.13.5 Iktos Recent Developments
  79. 6.14 AlmirallShare
  80. 6.14.1 AlmirallShare Company Information
  81. 6.14.2 AlmirallShare Business Overview
  82. 6.14.3 AlmirallShare AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AlmirallShare AI Drug Design Product Portfolio
  84. 6.14.5 AlmirallShare Recent Developments
7 North America
  1. 7.1 North America AI Drug Design Market Size (2021-2032)
  2. 7.2 North America AI Drug Design Market Size by Type
  3. 7.2.1 North America AI Drug Design Market Size by Type (2021-2026)
  4. 7.2.2 North America AI Drug Design Market Size by Type (2027-2032)
  5. 7.2.3 North America AI Drug Design Market Share by Type (2021-2032)
  6. 7.3 North America AI Drug Design Market Size by Application
  7. 7.3.1 North America AI Drug Design Market Size by Application (2021-2026)
  8. 7.3.2 North America AI Drug Design Market Size by Application (2027-2032)
  9. 7.3.3 North America AI Drug Design Market Share by Application (2021-2032)
  10. 7.4 North America AI Drug Design Market Size by Country
  11. 7.4.1 North America AI Drug Design Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI Drug Design Market Size by Country (2021-2026)
  13. 7.4.3 North America AI Drug Design Market Size by Country (2027-2032)
  14. 7.4.4 North America AI Drug Design Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI Drug Design Market Size (2021-2032)
  2. 8.2 Europe AI Drug Design Market Size by Type
  3. 8.2.1 Europe AI Drug Design Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI Drug Design Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI Drug Design Market Share by Type (2021-2032)
  6. 8.3 Europe AI Drug Design Market Size by Application
  7. 8.3.1 Europe AI Drug Design Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI Drug Design Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI Drug Design Market Share by Application (2021-2032)
  10. 8.4 Europe AI Drug Design Market Size by Country
  11. 8.4.1 Europe AI Drug Design Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI Drug Design Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI Drug Design Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI Drug Design Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI Drug Design Market Size (2021-2032)
  2. 9.2 China AI Drug Design Market Size by Type
  3. 9.2.1 China AI Drug Design Market Size by Type (2021-2026)
  4. 9.2.2 China AI Drug Design Market Size by Type (2027-2032)
  5. 9.2.3 China AI Drug Design Market Share by Type (2021-2032)
  6. 9.3 China AI Drug Design Market Size by Application
  7. 9.3.1 China AI Drug Design Market Size by Application (2021-2026)
  8. 9.3.2 China AI Drug Design Market Size by Application (2027-2032)
  9. 9.3.3 China AI Drug Design Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI Drug Design Market Size (2021-2032)
  2. 10.2 Asia AI Drug Design Market Size by Type
  3. 10.2.1 Asia AI Drug Design Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI Drug Design Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI Drug Design Market Share by Type (2021-2032)
  6. 10.3 Asia AI Drug Design Market Size by Application
  7. 10.3.1 Asia AI Drug Design Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI Drug Design Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI Drug Design Market Share by Application (2021-2032)
  10. 10.4 Asia AI Drug Design Market Size by Country
  11. 10.4.1 Asia AI Drug Design Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI Drug Design Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI Drug Design Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI Drug Design Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI Drug Design Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI Drug Design Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI Drug Design Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI Drug Design Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI Drug Design Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI Drug Design Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI Drug Design Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI Drug Design Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI Drug Design Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI Drug Design Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI Drug Design Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI Drug Design Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI Drug Design Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI Drug Design Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst